Literature DB >> 14691120

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.

Christopher L Amling1, Robert H Riffenburgh, Leon Sun, Judd W Moul, Raymond S Lance, Leo Kusuda, Wade J Sexton, Douglas W Soderdahl, Timothy F Donahue, John P Foley, Andrew K Chung, David G McLeod.   

Abstract

PURPOSE: To determine if obesity is associated with higher prostate specific antigen recurrence rates after radical prostatectomy (RP), and to explore racial differences in body mass index (BMI) as a potential explanation for the disparity in outcome between black and white men. PATIENTS AND METHODS: A retrospective, multi-institutional pooled analysis of 3,162 men undergoing RP was conducted at nine US military medical centers between 1987 and 2002. Patients were initially categorized as obese (BMI > or = 30 kg/m(2)), overweight (BMI 25 to 30 kg/m(2)), or normal (BMI < or = 25 kg/m(2)). For analysis, normal and overweight groups were combined (BMI < 30 kg/m(2)) and compared with the obese group (BMI > or = 30 kg/m(2)) with regard to biochemical recurrence (prostate-specific antigen > or = 0.2 ng/mL) after RP.
RESULTS: Of 3,162 patients, 600 (19.0%) were obese and 2,562 (81%) were not obese. BMI was an independent predictor of higher Gleason grade cancer (P <.001) and was associated with a higher risk of biochemical recurrence (P =.027). Blacks had higher BMI (P <.001) and higher recurrence rates (P =.003) than whites. Both BMI (P =.028) and black race (P =.002) predicted higher prostate specific antigen recurrence rates. In multivariate analysis of race, BMI, and pathologic factors, black race (P =.021) remained a significant independent predictor of recurrence.
CONCLUSION: Obesity is associated with higher grade cancer and higher recurrence rates after RP. Black men have higher recurrence rates and greater BMI than white men. These findings support the hypothesis that obesity is associated with progression of latent to clinically significant prostate cancer (PC) and suggest that BMI may account, in part, for the racial variability in PC risk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14691120     DOI: 10.1200/JCO.2004.03.132

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  107 in total

1.  Effects of dietary fat on spontaneous metastasis of Lewis lung carcinoma in mice.

Authors:  Lin Yan; Lana C DeMars
Journal:  Clin Exp Metastasis       Date:  2010-08-10       Impact factor: 5.150

Review 2.  Energetics in colorectal and prostate cancer.

Authors:  Jeffrey A Meyerhardt; Jing Ma; Kerry S Courneya
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

3.  Obesity and prostate cancer detection and progression.

Authors:  Stephen J Freedland; Alan W Partin
Journal:  Rev Urol       Date:  2004

4.  The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

Authors:  Saira Khan; Jianwen Cai; Matthew E Nielsen; Melissa A Troester; James L Mohler; Elizabeth T H Fontham; Laura H Hendrix; Laura Farnan; Andrew F Olshan; Jeannette T Bensen
Journal:  Prostate       Date:  2017-03-06       Impact factor: 4.104

5.  Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.

Authors:  Jason A Efstathiou; Kyounghwa Bae; William U Shipley; Gerald E Hanks; Miljenko V Pilepich; Howard M Sandler; Matthew R Smith
Journal:  Cancer       Date:  2007-12-15       Impact factor: 6.860

6.  Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levels.

Authors:  Keisuke Goto; Hirotaka Nagamatsu; Jun Teishima; Yuki Kohada; Shinsuke Fujii; Yoshimasa Kurimura; Koji Mita; Masanobu Shigeta; Satoshi Maruyama; Yoji Inoue; Mitsuru Nakahara; Akio Matsubara
Journal:  Mol Clin Oncol       Date:  2017-04-10

7.  Biological mediators of effect of diet and stress reduction on prostate cancer.

Authors:  Gordon A Saxe; Jacqueline M Major; Lindsey Westerberg; Srikrishna Khandrika; Tracy M Downs
Journal:  Integr Cancer Ther       Date:  2008-09       Impact factor: 3.279

8.  Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching.

Authors:  Ahmed Magheli; Soroush Rais-Bahrami; Bruce J Trock; Elizabeth B Humphreys; Alan W Partin; Misop Han; Mark L Gonzalgo
Journal:  Urology       Date:  2008-04-02       Impact factor: 2.649

9.  Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database.

Authors:  Jayakrishnan Jayachandran; William J Aronson; Martha K Terris; Joseph C Presti; Christopher L Amling; Christopher J Kane; Stephen J Freedland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

10.  Association of body mass index and prostate cancer mortality.

Authors:  Reina Haque; Stephen K Van Den Eeden; Lauren P Wallner; Kathryn Richert-Boe; Bhaskar Kallakury; Renyi Wang; Sheila Weinmann
Journal:  Obes Res Clin Pract       Date:  2013-08-06       Impact factor: 2.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.